Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe

Fumiyo Nakagawa, Rebecca Lodwick, Dominique Costagliola, Ard van Sighem, Carlo Torti, Daniel Podzamczer, Amanda Mocroft, Bruno Ledergerber, Maria Dorrucci, Alessandra Cozzi-Lepri, Klaus Jansen, Bernard Masquelier, Federico García, Stephane De Wit, Christoph Stephan, Niels Obel, Gerd Fätkenhaeuer, Antonella Castagna, Helen Sambatakou, Cristina MussiniJade Ghosn, Robert Zangerle, Xavier Duval, Laurence Meyer, Santiago Perez-Hoyos, Céline Fabre Colin, Jesper Kjaer, Genevieve Chene, Jesper Grarup, Andrew Phillips, Pursuing Later Treatment Options II (PLATO II) project team

    15 Citationer (Scopus)

    Abstract

    Despite the increasing success of antiretroviral therapy (ART), virologic failure of the 3 original classes [triple-class virologic failure, (TCVF)] still develops in a small minority of patients who started therapy in the triple combination ART era. Trends in the incidence and prevalence of TCVF over calendar time have not been fully characterised in recent years.
    OriginalsprogEngelsk
    TidsskriftJournal of acquired immune deficiency syndromes (1999)
    Vol/bind59
    Udgave nummer3
    Sider (fra-til)294-9
    Antal sider6
    DOI
    StatusUdgivet - 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe'. Sammen danner de et unikt fingeraftryk.

    Citationsformater